Better Big Pharma Stock: AbbVie vs. AstraZeneca
These A-list drugmakers must both contend with expiring patents, new drug uncertainties, and hungry competitors. But they're in different stages of their cyclical journeys.
via FOX BUSINESS NEWS https://fxn.ws/2J3x34g
No comments:
Post a Comment